WEDNESDAY
AFTERNOON, April 27, 1983
2:00 p.m. Scientific Sessions - Grand Ballroom
41. Complement and the Possibly Damaging Effects
of Cardio-pulmonary Bypass
JAMES K. KIRKLIN*,
EUGENE H. BLACKSTONE*,
JOHN W. KIRKLIN,
DENNIS E. CHENOWETH*,
ALBERTO. PACIFICO
and STEVE WESTABY*
Birmingham, Alabama;
LaJolla, California; London, England
The existence
of a damaging effect from cardiopulmonary bypass (CPB) per se, especially
in infants, and its possible mechanisms and prevention remain controversial.
Therefore, a prospective clinical study was made of the blood levels of C3a (a
product of complement activation), the usual clinical laboratory tests, and a
number of clinical events which were carefully recorded and categorized for
severity, in all patients undergoing open (n = 116) and closed (n = 12) cardiac
operations on two surgical services in a 6 week period. C3a levels were normal
(160-220 ng/ml) in the closed cases, and in the open cases were 1170 ng/ml (±
660-2050, p for difference from closed cases <0.0001), 870 (± 500-1510,
p<0.0001), and 280 (± 160-490, p = 0.4) at the end of CPB, 3 hours later,
and 20 hrs. later, respectively. By multivariate analysis, only the C3a levels
3 hours after CPB, young age, and longer CPB times increased the probability of
postoperative bleeding diathesis (p = 0.08, 0.06, 0.004 respectively),
importantly impaired cardiac performance (p = 0.02, <0.0001, 0.02) important
pulmonary dysfunction (p = 0.01, <0.0001, 0.03), and important renal
dysfunction (p = 0.02, <0.0001, >0.2). Only the same three variables were
related to the probability of important morbidity (all of the above events
combined, p = 0.008, <0.0001, 0.0002). The nature of the relations were such
that C3a levels above 1750 ng/ml tended to be associated with a high probability
(≥ 30%) of morbidity, the tendency increasing exponentially with younger
ages (particularly rapidly <1 yr) and longer CPB times (particularly >120
minutes). The hypothesis that results is that a damaging effect in the form of
a whole body inflammatory reaction, with complement activation, results from
even short periods of CPB; that very small patients are particularly
vulnerable; and that long CPB times add further damage. Many techniques allow
considerable suppression of these risk factors and good results, but more
knowledge is required for their complete neutralization.
*By Invitation
42. Management of Intracardiac Fungal Masses in
Premature Infants
JOHN E. FOKER*,
THEODORER. THOMPSON*,
JOHN L. BASS*, JOHN A. TILLELI*
and DANA E. JOHNSON*
Minneapolis,
Minnesota
Sponsored by: ROBERT
W. ANDERSON,
Minneapolis,
Minnesota
Intracardiac fungal masses can develop following
episodes of candidemia in premature infants with indwelling right atrial lines.
Previously, this diagnosis had only been made at autopsy in the cases described
in the literature. We report here the diagnosis and first successful surgical
removal of Candida-containing intracardiac masses in three premature infants.
Over the past four years, six premature newborns developed condidemia despite
oral nystatin prophylaxis. The right atrial lines were removed and the infants
treated with amphotericin B and 5-flucytosine. Echocardiograms revealed that
three (50%) had developed intracardiac masses. In two, a pedunculated solitary
mass was found within the right atrium. In these two patients the antifungal
therapy over the next 21-42 days controlled the Candida sepsis. By
echocardiography, however, the intracardiac masses did not decrease in size and
became quite mobile. In the third infant, masses were present from the right
atrium to the main pulmonary artery and surgical removal was recommended four
days after beginning antifungal therapy. In all three patients, the masses were
nearly the size of the main pulmonary artery and presumably contained viable
organisms. Because of concern for the risk of pulmonary embolism, surgical
removal was undertaken and two were removed using cardiopulmonary bypass (CPB).
One infant, however, weighed only 1300 grams and CPB seemed too hazardous. In
the latter case, the intraatrial mass was easily removed using inflow stasis of
30 seconds duration. In all three patients removal was grossly complete and the
masses were filled with Candida mycelia. All patients tolerated the operation
well and have been discharged home with a minimum follow-up of six months
without evidence of recurrent Candida infection. In summary, this report
documents that: (1) Echocardiography provides a noninvasive method of
diagnosing the development of intracardiac fungal masses and should be
performed in all infants who have had condidemia and a central venous line. (2)
The intracardiac masses do not appear to resolve even with prolonged systemic
antifungal therapy. (3) The masses can be safely removed even in the premature
infant, using either inflow stasis or CPB. (4) Surgical removal seems to be an
effective component of the management of these infants by eliminating the acute
threat of a large septic embolism and contributing to the elimination of the
focus of infection.
*By Invitation
43. Prospective Evaluation of Patients with
Chronic Respiratory Signs and Symptoms for the Presence of Occult Esophageal
Disease
TOM R. DEMEESTER,
CLEMENTE IASCONE*
and DAVID B. SKINNER
Chicago, Illinois
Seventy-seven patients with chronic respiratory
signs and symptoms of unknown etiology (18 chronic cough, 20 recurrent
pneumonia, 10 pulmonary fibrosis and 29 wheezing) were evaluated with a careful
clinical history, esophageal manometry and 24-hour esophageal pH monitoring for
the presence of esophageal disease. Symptoms of heartburn, regurgitation or
dysphagia were mild or absent in 90% of the patients. Fifty-four of the 77
patients had abnormal esophageal acid exposure on 24-hour pH monitoring and the
severity of acid exposure was similar in all groups with the exception of those
who wheezed. They had less acid exposure, mainly in the supine position
(p<.05). The lower esophageal sphincter pressure and length of abdominal
esophagus were similar in each group, but significantly less than normal. The
54 patients who refluxed were divided into four groups depending on the
severity of their respiratory symptoms as manifested by the presence of one or
more of the following complaints: morning cough, nocturnal cough, recurrent
pneumonia and wheezing spells. Group I had only one symptom; group II had two
symptoms, etc. Both the incidence of dysmotility of the body of the esophagus
and the occurrence of a respiratory symptom immediately preceeding or following
a reflux episode increased as the severity of their respiratory complaints
increased, suggesting that dysmotility may predispose to aspiration in those
who have abnormal acid exposure (Table I). Twelve patients were suspected
aspirators on the basis of respiratory symptoms occurring during or following an
reflux episode. This was commonly seen in patients complaining of only one
respiratory symptom suggesting that the esophageal disease was primary.
Patients with wheezing during or after a reflux episode had less acid exposure
suggesting that wheezing spells were not due to aspiration, but to a reflex
bronchial constriction triggered by the reflux episode. Seventeen patients were
operated on, and the results are shown on Table II.
Table 1
|
|
Severity of Respiratory Symptoms:
|
|
Relationship with Esophageal Body Dysmotility and
Reflux Episodes
|
|
|
|
Reflux Episodes
|
|
Severity of
|
|
Following or preceding
|
|
Respiratory symptoms
|
Dysmotility
|
Respiratory symptoms
|
|
# patients
|
|
# patients
|
%
|
# patients
|
%
|
|
Group 1
|
19
|
6
|
31.6
|
5
|
26.3
|
|
Group 2
|
12
|
5
|
41.7
|
5
|
41.7
|
|
Group 3
|
13
|
7
|
53.7
|
7
|
53.7
|
|
Group 4
|
10
|
7
|
70
|
6
|
60
|
Table 2
|
Results of Anti-Reflux Surgery For Respiratory Symptoms
|
|
|
Pre-Op Presence
|
Post-Op Improvement
|
|
Recurrent Pneumonia
|
9/17
|
7/9 78%
|
|
Wheezing
|
12/17
|
6/12 50%
|
|
Nocturnal Cough
|
14/17
|
12/14 86%
|
|
Morning Cough
|
10/17
|
8/10 80%
|
*By invitation
44. Treatment of Malignant Disease in Trachea and
Main Stem Bronchi by Carbon Dioxide Laser
RICHARD B. MCELVEIN
and GEORGE ZORN*
Birmingham, Alabama
The use of a carbon dioxide laser to erradicate
intralumenal malignant lesions of the trachea and main stem bronchi is
described.
Forty-three
patients, 28 males and 15 females ranging from 36 to 78 years have received
from one to five laser treatments to provide an improved airway with relief of
major respiratory tract obstruction. There has been one in-traoperative death
and two immediate postoperative deaths.
Improvement in
respiratory status has been accomplished in all surviving patients persisting
from 1 to 14 months. The carbon dioxide laser treatment does not cure cancer
but does provide an improved airway with low risk so other treatment can be
used.
A major
advantage of this form of treatment is decreased bleeding and the ability to
provide an improved airway. The disadvantages are the necessity for general
anesthesia and expense of the equipment.
45. Thymoma - Ten Year Experience
JOEL D. COOPER,
FARID SHAMJI*,
FREDERICK G.
PEARSON, THOMAS R.J. TODD*,
RIIVO ILVES* and
ROBERT J. GINSBERG
Toronto, Ontario
Between 1970 and 1980, 53 patients with a thymoma
were seen at the Toronto General Hospital. Two patients were inoperable at the
time of admission and the remaining 51 patients underwent surgical resection.
The results in these 51 patients, all of whom had a complete resection, forms
the basis of this report. Treatment consisted of resection alone in 30,
resection with preoperative radiation in 11, resection with postoperative
radiation in 8, and resection combined with preoperative and postoperative
radiation in 2.
Twenty-three
patients had invasive tumours and 28 had non-invasive tumours. Myasthenia
gravis was present in 25 patients (10 with invasive tumours and 15 with
non-invasive tumours). Current information is available on 46 of the 51
patients with a mean follow-up of 5.4 years.
Results
Of the 23
patients with invasive tumour, 7 patients are dead, 3 of unrelated causes, 2
from tumour recurrence, and 2 from complications associated with radiotherapy.
In addition 2 patients are alive with tumour recurrence (2 years and 10 years).
One patient is lost to follow-up.
Of the 21
patients with non-invasive tumours, 3 patients are dead, all of unrelated
causes. No patient has developed recurrent tumour, 4 patients are lost to
follow-up.
Contrary to
earlier experience, the presence of myasthenia gravis did not alter the
prognosis: of 23 patients with invasive tumours, there were 3 deaths in the 10
patients with myasthenia gravis and 4 deaths in the 13 patients without
myasthenia gravis. The mean survival time was not affected by the presence
of myasthenia gravis and no patient had died of myasthenia.
We conclude
that surgical excision for thymoma is associated with a very favourable
prognosis and that the long term survival is not significantly affected by the
presence of myasthenia gravis.
*By Invitation
46. Surgical Treatment of Aneurysm of the
Ascending Aorta with Aortic Insufficiency - A Selective Approach
DOUGLAS P. GREY*,
DAVID A. OTT*
and DENTON A. COOLEY
Jacksonville,
Florida; Houston, Texas
The selection of an appropriate surgical technique
for repair of aneurysm of the ascending aorta with aortic insufficiency
(AATA-AVR) is unsettled. Placement of a supra-coronary graft is a compromise if
the coronary ostia are displaced cephalad by the aneurysm; whereas, insertion
of a valved conduit is difficult and unnecessary if the coronary ostia are
normally placed.
From June 1979
to May 1982, 123 patients underwent repair of AATA-AVR. Mean age was 46.4
years. Annuloaortic ectasia was the most common indication for repair (44/123,
35.8%), followed by acute and chronic dissection (39/123, 31.7%). Twelve
patients had previous operations on the ascending aorta or aortic valve, and
five patients had undergone prior AATA-AVR using conventional methods (separate
valve and supra-coronary graft). Seventy-two patients (58.5%) underwent
composite replacement with coronary reimplantation, and fifty-one patients had
repair using the conventional technique. Cardiopulmonary bypass methods, times,
and postoperative complications were comparable between the two groups.
Hospital
mortality for the whole series was 7.4% (9/122), with 4.2% (3/71) in patients
having composite replacement and 11.8% (6/51) in patients having a conventional
repair (p = N.S.). Five Jehovah's Witness patients survived. One patient
committed suicide on the third post-operative day and was eliminated from
subsequent calculations. Of sixty patients who have been followed locally for a
total of 1183 patient-months, three died: two new dissections (6 weeks, 14
months) and one death without autopsy (2 months). Notably, no patient has
required reoperation for conduit malfunction or required repair of aneurysm
below a supra-coronary graft. Clinical anatomic assessment at operation should
determine the technique of repair employed, based on the degree of displacement
of the coronary ostia relative to the aortic annulus.
4:00 p.m. Adjournment
*By Invitation